Adult Hemoglobinopathy Testing Market Trends Shaping Clinical Diagnostics
The global adult hemoglobinopathy testing market is set for consistent growth over the next decade, reflecting rising clinical demand for accurate diagnosis and long-term monitoring of inherited blood disorders. The market is estimated to expand from US$ 2.1 billion in 2026 to US$ 3.4 billion by 2033, registering a compound annual growth rate (CAGR) of 5.5% during the forecast period. This growth trajectory underscores the increasing importance of diagnostic testing as adult populations living with hemoglobinopathies continue to expand worldwide.